Baylor College of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2020

  1. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    Journal of Clinical Investigation, Vol. 130, Núm. 9, pp. 4871-4887

2011

  1. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

    Clinical Proteomics, Vol. 8, Núm. 1

2010

  1. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

    Breast Cancer Research, Vol. 12, Núm. 3